DZ3368A1 - 3-AZABICYCLO DERIVATIVES [3.1.0] HEXANE HAVING AN AFFINITY FOR THE OPIOID RECEPTOR - Google Patents

3-AZABICYCLO DERIVATIVES [3.1.0] HEXANE HAVING AN AFFINITY FOR THE OPIOID RECEPTOR

Info

Publication number: DZ3368A1
Authority: DZ; Algeria
Prior art keywords: hexane; affinity; opioid receptor; azabicyclo derivatives; azabicyclo
Prior art date: 2000-06-23

Application number

DZ013368A

Other languages

French (fr)

Inventor

Bernard Joseph Banks

Douglas James Critcher

Ashley Edward Fenwick

David Morris Gethin

Stephen Paul Gibson

Graham Lunn

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-23

Filing date

2001-06-07

Publication date

2001-12-27

2001-06-07 Application filed by Pfizer filed Critical Pfizer

2001-12-27 Application granted granted Critical

2001-12-27 Publication of DZ3368A1 publication Critical patent/DZ3368A1/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Addiction (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Nutrition Science (AREA)
Gynecology & Obstetrics (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DZ013368A 2000-06-23 2001-06-07 3-AZABICYCLO DERIVATIVES [3.1.0] HEXANE HAVING AN AFFINITY FOR THE OPIOID RECEPTOR DZ3368A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0015562.2A GB0015562D0 (en)	2000-06-23	2000-06-23	Heterocycles
PCT/IB2001/001035 WO2001098267A1 (en)	2000-06-23	2001-06-07	3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity

Publications (1)

Publication Number	Publication Date
DZ3368A1 true DZ3368A1 (en)	2001-12-27

Family

ID=9894368

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ013368A DZ3368A1 (en)	2000-06-23	2001-06-07	3-AZABICYCLO DERIVATIVES [3.1.0] HEXANE HAVING AN AFFINITY FOR THE OPIOID RECEPTOR

Country Status (34)

Country	Link
EP (1)	EP1292574A1 (en)
JP (1)	JP2004512263A (en)
KR (1)	KR20040002386A (en)
CN (1)	CN1639121A (en)
AP (1)	AP2002002698A0 (en)
AR (1)	AR028969A1 (en)
AU (1)	AU781837B2 (en)
BG (1)	BG107329A (en)
BR (1)	BR0111867A (en)
CA (1)	CA2412188A1 (en)
CZ (1)	CZ20023967A3 (en)
DO (1)	DOP2001000187A (en)
DZ (1)	DZ3368A1 (en)
EA (1)	EA005117B1 (en)
GB (1)	GB0015562D0 (en)
HR (1)	HRP20020998A2 (en)
HU (1)	HUP0301228A3 (en)
IL (1)	IL153427A0 (en)
IS (1)	IS6637A (en)
MA (1)	MA26915A1 (en)
MX (1)	MXPA02012878A (en)
NO (1)	NO20026168L (en)
NZ (1)	NZ523141A (en)
OA (1)	OA12293A (en)
PA (1)	PA8519401A1 (en)
PE (1)	PE20020253A1 (en)
PL (1)	PL365956A1 (en)
SK (1)	SK17172002A3 (en)
TN (1)	TNSN01094A1 (en)
UA (1)	UA73176C2 (en)
UY (1)	UY26787A1 (en)
WO (1)	WO2001098267A1 (en)
YU (1)	YU91802A (en)
ZA (1)	ZA200210278B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0401884A2 (en) *	2001-10-22	2005-01-28	Pfizer Products Inc.	3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists and pharmaceutical compositions containing them
EP2074997A1 (en) *	2002-05-17	2009-07-01	Tioga Pharmaceuticals, Inc.	Use of Asimadoline for the treatment of digestive disorders
DE10259245A1 (en)	2002-12-17	2004-07-01	Merck Patent Gmbh	Derivatives of asimadolin with covalently bound acids
PL2070922T3 (en)	2004-02-23	2012-01-31	Glaxo Group Ltd	Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
GB0507680D0 (en) *	2005-04-15	2005-05-25	Glaxo Group Ltd	Compounds
WO2006133945A1 (en) *	2005-06-14	2006-12-21	Glaxo Group Limited	Novel compounds
DE602007012531D1 (en) *	2006-04-03	2011-03-31	Glaxo Group Ltd	AZABICYCLOA3.1.0 OXIDE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS
EP2136801B1 (en)	2007-03-30	2012-08-29	Tioga Pharmaceuticals, Inc.	Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
TWI423801B (en) *	2007-08-27	2014-01-21	Theravance Inc	8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
JP5736040B2 (en)	2010-06-11	2015-06-17	ローズテクノロジーズ	Transition metal catalyzed process and its use for the preparation of N-allyl compounds
BR112013007566A2 (en)	2010-09-28	2016-08-02	Panacea Biotec Ltd	new bicyclic compounds
ES2774349T3 (en) *	2013-11-20	2020-07-20	Sanwa Kagaku Kenkyusho Co	Derived from 3-azabicyclo [3.1.0] hexane and its use for medical purposes
CN113307760A (en)	2015-05-20	2021-08-27	宇部兴产株式会社	Novel crystal of salt of 3-azabicyclo [3.1.0] hexane derivative and medical application thereof
KR20190129867A (en)	2017-02-17	2019-11-20	트레베나, 인코포레이티드.	5-membered aza-heterocycle-containing delta-opioid receptor modulating compounds, and methods of using and preparing the same
CA3052479A1 (en)	2017-02-17	2018-08-23	Trevena, Inc.	7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
AU2018229062A1 (en)	2017-03-02	2019-09-26	Ube Industries, Ltd.	Therapeutic agent for alcohol use disorders
CN108250088B (en) *	2018-01-04	2020-10-30	四川之江高新材料股份有限公司	Preparation method of N, N, N '-trimethyl-N' -hydroxyethyl bisaminoethylether

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3065230A (en) *	1959-03-16	1962-11-20	Burroughs Wellcome Co	Azabicyclohexanes and method of preparing them
CA1321792C (en) *	1987-04-16	1993-08-31	Eli Lilly And Company	Piperidine opioid antagonists
US5159081A (en) *	1991-03-29	1992-10-27	Eli Lilly And Company	Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
DE4341403A1 (en) *	1993-12-04	1995-06-08	Basf Ag	N-substituted 3-azabicycloalkane derivatives, their preparation and use
TWI244481B (en) *	1998-12-23	2005-12-01	Pfizer	3-azabicyclo[3.1.0]hexane derivatives useful in therapy
PE20001420A1 (en) *	1998-12-23	2000-12-18	Pfizer	CCR5 MODULATORS

2000
- 2000-06-23 GB GBGB0015562.2A patent/GB0015562D0/en not_active Ceased
2001
- 2001-06-06 DO DO2001000187A patent/DOP2001000187A/en unknown
- 2001-06-07 YU YU91802A patent/YU91802A/en unknown
- 2001-06-07 CZ CZ20023967A patent/CZ20023967A3/en unknown
- 2001-06-07 MX MXPA02012878A patent/MXPA02012878A/en unknown
- 2001-06-07 PL PL01365956A patent/PL365956A1/en not_active Application Discontinuation
- 2001-06-07 SK SK1717-2002A patent/SK17172002A3/en unknown
- 2001-06-07 DZ DZ013368A patent/DZ3368A1/en active
- 2001-06-07 OA OA1200200386A patent/OA12293A/en unknown
- 2001-06-07 AP APAP/P/2002/002698A patent/AP2002002698A0/en unknown
- 2001-06-07 KR KR1020027017503A patent/KR20040002386A/en not_active Application Discontinuation
- 2001-06-07 BR BR0111867-6A patent/BR0111867A/en not_active IP Right Cessation
- 2001-06-07 HU HU0301228A patent/HUP0301228A3/en unknown
- 2001-06-07 WO PCT/IB2001/001035 patent/WO2001098267A1/en not_active Application Discontinuation
- 2001-06-07 JP JP2002504223A patent/JP2004512263A/en not_active Withdrawn
- 2001-06-07 CA CA002412188A patent/CA2412188A1/en not_active Abandoned
- 2001-06-07 IL IL15342701A patent/IL153427A0/en unknown
- 2001-06-07 CN CNA018116086A patent/CN1639121A/en active Pending
- 2001-06-07 EP EP01936728A patent/EP1292574A1/en not_active Withdrawn
- 2001-06-07 NZ NZ523141A patent/NZ523141A/en unknown
- 2001-06-07 EA EA200201269A patent/EA005117B1/en not_active IP Right Cessation
- 2001-06-07 AU AU62591/01A patent/AU781837B2/en not_active Ceased
- 2001-06-12 PA PA20018519401A patent/PA8519401A1/en unknown
- 2001-06-21 UY UY26787A patent/UY26787A1/en not_active Application Discontinuation
- 2001-06-21 PE PE2001000604A patent/PE20020253A1/en not_active Application Discontinuation
- 2001-06-21 AR ARP010102957A patent/AR028969A1/en unknown
- 2001-06-22 TN TNTNSN01094A patent/TNSN01094A1/en unknown
- 2001-07-06 UA UA20021210406A patent/UA73176C2/en unknown
2002
- 2002-11-28 BG BG107329A patent/BG107329A/en unknown
- 2002-11-28 IS IS6637A patent/IS6637A/en unknown
- 2002-12-12 HR HR20020998A patent/HRP20020998A2/en not_active Application Discontinuation
- 2002-12-16 MA MA26955A patent/MA26915A1/en unknown
- 2002-12-19 ZA ZA200210278A patent/ZA200210278B/en unknown
- 2002-12-20 NO NO20026168A patent/NO20026168L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20026168D0 (en)	2002-12-20
CZ20023967A3 (en)	2004-02-18
HUP0301228A2 (en)	2003-08-28
PA8519401A1 (en)	2002-12-30
EA005117B1 (en)	2004-10-28
AU781837B2 (en)	2005-06-16
CN1639121A (en)	2005-07-13
IL153427A0 (en)	2003-07-06
HUP0301228A3 (en)	2005-08-29
KR20040002386A (en)	2004-01-07
NZ523141A (en)	2005-06-24
WO2001098267A1 (en)	2001-12-27
OA12293A (en)	2004-03-18
JP2004512263A (en)	2004-04-22
PL365956A1 (en)	2005-01-24
SK17172002A3 (en)	2004-09-08
EA200201269A1 (en)	2003-06-26
MA26915A1 (en)	2004-12-20
UA73176C2 (en)	2005-06-15
YU91802A (en)	2006-05-25
BG107329A (en)	2003-07-31
UY26787A1 (en)	2002-01-31
ZA200210278B (en)	2003-12-19
AU6259101A (en)	2002-01-02
TNSN01094A1 (en)	2005-11-10
GB0015562D0 (en)	2000-08-16
AR028969A1 (en)	2003-05-28
NO20026168L (en)	2003-02-18
HRP20020998A2 (en)	2004-02-29
PE20020253A1 (en)	2002-04-08
BR0111867A (en)	2003-07-01
DOP2001000187A (en)	2002-03-30
EP1292574A1 (en)	2003-03-19
IS6637A (en)	2002-11-28
MXPA02012878A (en)	2003-05-14
AP2002002698A0 (en)	2002-12-31
WO2001098267A8 (en)	2003-02-27
CA2412188A1 (en)	2001-12-27

Publication	Publication Date	Title
DZ3368A1 (en)	2001-12-27	3-AZABICYCLO DERIVATIVES [3.1.0] HEXANE HAVING AN AFFINITY FOR THE OPIOID RECEPTOR
HK1072052A1 (en)	2005-08-12	3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
ATE335725T1 (en)	2006-09-15	3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS
MA27032A1 (en)	2004-12-20	NEW INDOLE AFFINITY DERIVATIVES FOR THE 5-HT6 RECEPTOR
ATE354570T1 (en)	2007-03-15	5,6-DIARYL-PYRAZINEAMIDE DERIVATIVES AS CB1 ANTAGONISTS
ZA991413B (en)	1999-08-30	Substituted quinoxaline derivatives as interleukin-8 receptor antagonists.
CY2010003I2 (en)	2012-01-25	BETA-2 ADRENOREGIC RECEPTOR ANTAGONISTS
PL365377A1 (en)	2005-01-10	Amide derivatives as nmda receptor antagonists
DE60214428D1 (en)	2006-10-12	1, 4-DIHYDRO-1, 4-DIPHENYLPYRIDINE DERIVATIVES
IL158807A0 (en)	2004-05-12	5-ht receptor ligands and uses thereof
GB0113352D0 (en)	2001-07-25	Adjustable swivel assembly for seat suspension
MXPA03006991A (en)	2003-11-18	Piperidinee derivatives as neurokinin 1 antagonists.
HK1042699A1 (en)	2002-08-23	N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists.
HK1060065A1 (en)	2004-07-30	Use of an aldosterone antagonist for the treatmentor prohpylaxis of aldosteronemediated pathogenic effects
MXPA03003892A (en)	2003-07-28	Bombesin receptor antagonists.
MXPA03004414A (en)	2003-09-04	Bombesin receptor antagonists.
NO995081D0 (en)	1999-10-18	Device for H.323 proxy
NL1022106A1 (en)	2003-06-10	Base for caravans.
FR2782251B1 (en)	2000-10-13	BASE FOR FURNITURE
FI20000214A (en)	2001-08-02	Swiveling device for turning the vehicle seat
ZA99171B (en)	1999-07-12	Piperazino derivatives as neurokinin antagonists.
FIU20000198U0 (en)	2000-04-28	SEAT
FI20011745A0 (en)	2001-08-31	Swiveling device for turning the vehicle seat
FI20000363A (en)	2001-08-18	Seat swivel seat
ES1049951Y (en)	2002-06-01	PERFECTED HANGER.